Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;332:1213 (20 May), doi:10.1136/bmj.332.7551.1213-a
| The first 150 words of the full text of this article appear below. |
EDITORHoare and Li suggest that patients with pneumonia should receive antibiotics intravenously if they have a CURB score of at least 3, or contraindications to oral treatment, which may include malabsorption, impaired consciousness, or risk of aspiration.1 They also assert that intravenous antibiotics should be changed to oral treatment as soon as possible.
These two points are in accordance with current guidelines from the British Thoracic Society and are designed to limit the prescription of intravenous antibiotics when not indicated. This is because of their undesirable effect on microbial resistance, as well as their side effect profile and greater cost.
We recently audited the treatment of pneumonia in our district general hospital and found that antibiotics were prescribed intravenously to 54% of patients (28 out of 52) with a CURB score of 0 or 1. These patients do not qualify for intravenous antibiotics according to the current guidelines.
D Owen, senior house officer (medicine)
david.owen@doctors.net.uk, Queen Elizabeth II Hospital, Welwyn Garden City, Hertfordshire AL7 4HQ
Tamara Shiner, senior house officer (medicine), Ramachandran Sivakumar, specialist registrar (care of elderly), Richard Dent, consultant (respiratory medicine)
Queen Elizabeth II Hospital, Welwyn Garden City, Hertfordshire AL7 4HQ
Christopher Hilton, preregistration house officer (medicine)
Chelsea and Westminster Hospital, London SW10 9NH
Read all Rapid Responses